论文部分内容阅读
本文对筛选出HBsAg或HBeAg阳性孕妇产前检测HBV-白蛋白受体滴度并对其分娩婴儿随访观察母婴传播机率。23例HBeAg阳性组中有18名婴儿慢性携带HBsAg(78.26％),17名HBV-白蛋白受体滴度为1∶100者中有15名婴儿慢性携带(88.23％),其中1∶1000滴度9名婴儿慢性携带为100％。结果表明HBV-白蛋白受体是一项比HBeAg更能反映传染性的检测指标,是目前研究乙型肝炎母婴传播和考核乙型肝炎疫苗阻断传播效果的最理想指标。
In this paper, HBsAg or HBeAg-positive pregnant women were selected for prenatal detection of HBV-albumin receptor titers and follow-up of their births to observe the mother-child transmission probability. Twenty-eight of 23 HBeAg-positive patients were chronic carriers of HBsAg (78.26%) and 15 infants (88.23%) were chronic carriers of 17 HBV-albumin receptor titer of 1: Nine babies had a chronic carrier of 100%. The results show that HBV-albumin receptor is a better indicator of infection than HBeAg, which is the best indicator to study the effect of hepatitis B virus (HBV) transmission and block the transmission of hepatitis B vaccine.